Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally
- 12/19/2025 12:35:43 PM
- Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional (HCP) experiences, enabling teams to focus on strategic and meaningful customer interactions.
- New evidence challenges understanding of Parkinson’s disease
- 12/18/2025 9:46:14 PM
- A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson’s disease treatments. Published in Nature Neuroscience, the research found dopamine does not set the speed or force of each movement, as had been thought.
- Mayo Clinic researchers develop AI-ECG model to diagnose liver disease earlier
- 12/18/2025 9:39:06 PM
- As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease and resulting liver scarring or cirrhosis also are rising.
- ‘Free’ drug samples aren’t really free
- 12/18/2025 12:09:28 PM
- As lawmakers debate ways to reduce prescription drug spending, one costly practice often escapes attention: providing drug samples. Drug companies spend over $41 billion each year marketing to doctors.
- Reported use of most drugs remains low among U.S. teens
- 12/17/2025 10:49:55 PM
- For the fifth year in a row, use of most substances among teenagers in the United States has continued to hover around the low-water mark reached in 2021.
- PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
- 12/17/2025 10:38:25 PM
- • PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after surgery in cisplatin-eligible patients with muscle-invasive bladder cancer • Positive EV-304 data, combined with the recent unprecedented results from the EV-303 trial, highlight the potential of this …
- The Finnish Medicines Agency and Tieto Tech Consulting join forces to develop national pharmaceutical information repository
- 12/17/2025 12:29:00 PM
- The Finnish Medicines Agency (Fimea) has chosen Tieto Tech Consulting (formerly Tietoevry Create) as its partner to develop the national pharmaceutical information repository called Farmasto.
- AMA report: Health insurance giants tighten grip on U.S. markets
- 12/17/2025 12:17:29 AM
- The American Medical Association (AMA) released new data showing which health insurers hold the largest share of the commercial and Medicare Advantage markets—spots where limited competition leaves millions of Americans with too few choices and rising costs.
- COVID-19 vaccination significantly reduces risk to pregnant women and baby
- 12/16/2025 10:29:06 PM
- Pregnant people who received a COVID-19 vaccine were far less likely to experience severe illness or deliver their babies prematurely, according to a major new UBC-led study published in JAMA. Drawing on data from nearly 20,000 pregnancies across Canada, the research found that vaccination was strongly associated with lower risks of hospitalization, intensive care …
- Healthcare Organizations Enhance Efficiency with Oracle Fusion Cloud Applications
- 12/16/2025 8:43:40 AM
- Leading healthcare organizations are implementing Oracle Fusion Cloud Applications to help increase productivity, reduce costs, and enhance the experience they deliver to employees and patients.
- Author Felicity Jean Transforms Alzheimer’s Caregiving Into a Journey of Resilience in “Free Fall”
- 12/15/2025 7:30:45 PM
- In “Free Fall,” author Felicity Jean delivers a raw, unfiltered memoir about what it means to love and lose someone who is still standing right in front of you.
- FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews
- 12/15/2025 4:11:42 PM
- The U.S. Food and Drug Administration (FDA) today removed a key limitation on the use of real-world evidence (RWE) used in drug and device applications reviews.
- Mick Farrell, Chairman and CEO of Resmed, Named Chair of AdvaMed Board of Directors
- 12/15/2025 10:06:08 AM
- AdvaMed, the Medtech Association, announced Michael “Mick” Farrell, chairman and CEO of Resmed Inc. (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, will be the next chair of the AdvaMed Board of Directors.
- Partners in Digital Health Launches Multilingual Accessibility for Global Audience Research Access and Citation
- 12/15/2025 9:04:50 AM
- Partners in Digital Health, publisher of Blockchain in Healthcare Today ( BHTY ), has launched a new accessibility and citation campaign that democratizes access to leading edge blockchain tech in healthcare research, powered by CACTUS AI Solutions, a global leader in research communication technology.
- Home-Delivered Groceries Improve Blood Sugar Control for People with Diabetes Facing Food Insecurity
- 12/11/2025 7:52:51 AM
- A new study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, evaluated a 12-week home-delivered food and education program among adults in Northwest Arkansas.
- Carrie Owen Plietz named group senior vice president, chief operating officer, Care Delivery
- 12/9/2025 12:05:43 PM
- Kaiser Permanente has appointed Carrie Owen Plietz as group senior vice president and chief operating officer, Care Delivery, for the organization’s national integrated care and coverage structure.
- Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting
- 12/8/2025 1:10:34 PM
- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that new data evaluating XOSPATA™ (gilteritinib) across FMS-like tyrosine kinase 3 mutation-positive (FLT3m+) acute myeloid leukemia (AML), including in relapsed or refractory (R/R), newly diagnosed and post-transplant maintenance settings, will be presented at the upcoming American …
- AMA statement on ACIP meeting 2025
- 12/8/2025 12:11:51 PM
- Statement attributable to: Sandra Adamson Fryhofer, MD Trustee, American Medical Association “The Advisory Committee on Immunization Practice’s (ACIP) vote to weaken the birth-dose recommendation for the Hepatitis B vaccine is reckless and undermines decades of public confidence in a proven, lifesaving vaccine.
- The importance of hepatitis B vaccination for newborns
- 12/8/2025 11:29:02 AM
- Hepatitis B is an infection of the liver caused by the contagious hepatitis B virus that spreads through contact with infected blood and body fluids.
- Breakthrough Accessibility Initiative: THMT Research Now Available to Global Audiences
- 12/8/2025 8:00:00 AM
- We’re excited to announce Telehealth and Medicine Today (THMT) and CACTUS AI Solutions are bringing cutting edge telehealth and AI research to practitioners, policymakers, and patients around the globe! Selected articles are now enhanced with: Multilingual Access - Full translations and summaries in Chinese, German, Spanish, and English.